Advertisement
U.S. Markets closed

Cytokinetics, Incorporated (KK3A.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
64.50-1.00 (-1.53%)
At close: 09:50PM CET
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
6.68B7.40B2.68B2.88B3.09B4.07B
Enterprise Value
6.81B7.59B2.85B2.96B3.05B3.95B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
893.94999.93277.9030.5129.6226.33
Price/Book (mrq)
N/AN/AN/AN/AN/AN/A
Enterprise Value/Revenue
904.344.54k7.54k3.41k662.252.02k
Enterprise Value/EBITDA
-14.91-66.85-25.11-26.09-26.29-33.04

Trading Information

Stock Price History

Beta (5Y Monthly) 0.69
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 399.50
52 Week Low 325.20
50-Day Moving Average 368.01
200-Day Moving Average 344.28

Share Statistics

Avg Vol (3 month) 389
Avg Vol (10 day) 351
Shares Outstanding 5103M
Implied Shares Outstanding 6N/A
Float 8102.08M
% Held by Insiders 10.88%
% Held by Institutions 1113.77%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jun 25, 2013

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-7,620.69%

Management Effectiveness

Return on Assets (ttm)-33.73%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)7.53M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-14.60%
Gross Profit (ttm)N/A
EBITDA -484.31M
Net Income Avi to Common (ttm)-526.24M
Diluted EPS (ttm)-5.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)614.82M
Total Cash Per Share (mrq)5.97
Total Debt (mrq)756.91M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.12
Book Value Per Share (mrq)-3.80

Cash Flow Statement

Operating Cash Flow (ttm)-414.33M
Levered Free Cash Flow (ttm)-261.37M